Eko Analysis Software vs KardiaPro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Eko Analysis Software

by Eko Devices

KardiaPro

by AliveCor

AI Verdict

Eko Analysis Software focuses on point-of-care detection of cardiovascular diseases, primarily through AI-powered analysis of heart sounds and ECGs captured by their digital stethoscopes. KardiaPro, on the other hand, is a broader remote patient monitoring platform that manages ECG, blood pressure, and weight data from various compatible devices, with AI specifically for arrhythmia detection. While both offer FDA-cleared AI for cardiac rhythm analysis, Eko's strength lies in its integrated stethoscope and murmur detection, while KardiaPro excels in comprehensive remote data management and trend analysis.

Choose Eko Analysis Software if…

Choose Eko Analysis Software if your primary need is to enhance in-office physical exams with AI-powered auscultation for early detection of cardiovascular diseases. It integrates directly with Eko's digital stethoscopes to provide real-time analysis of heart sounds and ECGs, assisting clinicians in identifying heart murmurs and atrial fibrillation during routine appointments.

View Eko Analysis Software →

Choose KardiaPro if…

Choose KardiaPro if you require a comprehensive web-based platform for remote patient monitoring of ECG, blood pressure, and weight data. This tool is ideal for managing and reviewing longitudinal cardiac data between appointments, enabling healthcare professionals to track trends and make informed clinical decisions for patients using KardiaMobile devices at home.

View KardiaPro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Eko Analysis Software	KardiaPro
Pricing	Freemium with subscription for full features	Contact for pricing
Deployment	Cloud-based	Cloud-hosted, Web-based
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Analysis Software

Eko Analysis Software integrates with Eko's digital stethoscopes and a mobile app, offering real-time visualization, recording, and sharing of patient data, which is highly praised for its user-friendliness and intuitive workflows. While KardiaPro also offers a user-friendly web portal and mobile app integration, some user reviews for Kardia devices (which integrate with KardiaPro) mention issues with the app disconnecting or requiring frequent sign-ins, which could hinder usability in a clinical setting.

Clinical Value

Eko Analysis Software

Both tools offer FDA-cleared AI for cardiac condition detection. Eko Analysis Software focuses on heart murmurs and atrial fibrillation (AFib) detection, with studies showing its AI algorithm's accuracy comparable to expert cardiologists for murmur detection. KardiaPro, while also FDA-cleared for arrhythmia detection, integrates with a broader range of biometric data (blood pressure, weight) but its core strength lies in ECG analysis. The direct integration of AI for auscultation in Eko provides a unique and significant clinical advantage at the point of care.

Pricing & Value

Eko Analysis Software

Eko Analysis Software offers a freemium model with a clear subscription for full AI-powered features, including a complimentary trial period with stethoscope purchase. KardiaPro requires contacting them directly for pricing, which can be a barrier to transparency and initial assessment of value. While KardiaPro mentions reimbursable CPT codes, Eko's transparent pricing and trial offer a more accessible entry point for individual clinicians and smaller practices.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness. Eko offers solutions for health systems, including telehealth livestreaming and secure cloud storage, and is HIPAA and GDPR compliant with SOC 2 Type 2 audits. KardiaPro also provides a comprehensive web-based portal for remote monitoring, supports EHR integration, and is HIPAA-compliant and SOC-2 certified. Both are well-suited for larger healthcare organizations due to their compliance and integration capabilities.

Innovation

Eko Analysis Software

Eko Analysis Software's innovation lies in integrating AI directly with digital stethoscopes for real-time, AI-powered auscultation, including the ability to differentiate structural from innocent murmurs and provide timing. This directly augments a fundamental clinical examination. KardiaPro's innovation is in its comprehensive remote monitoring platform for various cardiac data, but Eko's direct AI-powered enhancement of the physical exam represents a more novel application of AI in the immediate diagnostic workflow.

Support & Docs

Tie

Both companies offer support, though specific details on documentation are not extensively provided in the structured facts. Eko provides a help center, FAQs, and contact options for sales and support. KardiaPro's information suggests support for integration and patient management, but explicit details on documentation or direct support channels are less prominent in the provided data. Without more detailed information for both, it's difficult to definitively pick a winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Eko Analysis Software	KardiaPro
Name	Eko Analysis Software	KardiaPro
Company	Eko Devices	AliveCor
Description	FDA-cleared AI-powered tool that integrates with Eko's digital stethoscopes and mobile app to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation.	Comprehensive web-based portal for remote monitoring of patient ECG, blood pressure, and weight data, with FDA-cleared AI for arrhythmia detection and other cardiac determinations.
Key AI Detections	FDA-cleared AI for heart murmur detection, FDA-cleared AI for atrial fibrillation (AFib) detection, Detection of normal sinus rhythm	FDA-cleared AI for arrhythmia detection
Data Monitored	Heart sounds and ECGs	ECG, blood pressure, and weight data
Integration with Devices	Eko's digital stethoscopes and mobile app	KardiaMobile and KardiaMobile 6L devices, KardiaStation
Specialties	Cardiology, Emergency Medicine, Internal Medicine	Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Eko Analysis Software and KardiaPro.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for different specialties, and what is the learning curve for physicians?

Eko Analysis Software integrates with Eko's digital stethoscopes and mobile app, allowing for real-time AI analysis alongside enhanced audio, waveform visualization, and guided exams during routine physicals. This aims to provide clearer, more actionable results at the point of care without disrupting the existing workflow. KardiaPro, a web-based portal, is designed for remote monitoring of ECG, blood pressure, and weight data, integrating with KardiaMobile devices and supporting EHR/third-party interoperability. It offers a customizable ECG inbox and automated summary reports to streamline the review of remote patient data. Both systems are designed to be user-friendly, with KardiaMobile devices being described as easy to use.

What is the depth of EHR integration for both tools, and how does it facilitate data management and clinical decision-making?

Eko Analysis Software integrates with EHRs, enabling clinicians to open the dashboard within their own system, facilitating the inclusion of cardiopulmonary data into the patient's chart. It supports real-time transmission of audio, ECG, and other vitals, and can push AI analysis results to the EHR via PDF or an anonymous URL. KardiaPro offers EHR integration, allowing patient ECG data to be automatically pulled into the EHR system, and is listed in Epic's App Orchard Marketplace for easy integration. This aims to provide seamless access to medical-grade heart data within existing workflows.

What are the accuracy and sensitivity of each tool's AI for detecting cardiovascular conditions, and what specific conditions do they identify?

Eko Analysis Software's AI detects structural heart murmurs and atrial fibrillation (AFib). Its AFib detection has shown 95% sensitivity and 94% specificity, while its murmur detection aims to identify clinically meaningful murmurs and reduce alerts for innocent ones. Earlier versions of Eko's AI for AFib detection showed 98.9% sensitivity and 96.9% specificity, and murmur detection showed 87.6% sensitivity and 87.8% specificity. KardiaPro utilizes FDA-cleared AI for arrhythmia detection, integrating with KardiaMobile devices. Kardia devices can detect six common arrhythmias, including AFib, bradycardia, tachycardia, Sinus Rhythm with PVCs, Sinus Rhythm with SVE, and Sinus Rhythm with Wide QRS, with AFib detection accuracy comparable to physician judgment.

Beyond HIPAA, what additional security measures and certifications do these tools have to protect patient data?

Eko Cloud is SOC2 certified, ensuring data is encrypted in transit and at rest. KardiaPro is SOC-2 certified and ISO 27001 certified, indicating adherence to stringent security standards and a risk-based approach to information security management. AliveCor also holds Cyber Essentials and HITRUST certifications.

Can physicians access customer references or case studies to understand real-world implementation and time-to-value for these tools?

While specific customer references or case studies aren't detailed in the provided information, both companies highlight the benefits of their tools in clinical practice. Eko emphasizes early disease detection and enhanced patient care, with its platform used by over 500,000 healthcare professionals. KardiaPro is presented as a tool for efficient patient monitoring and analysis, with evidence suggesting it can reduce the need for long-term cardiac monitors and urgent healthcare visits for AFib patients.

What audit-trail features are available in each tool to support compliance and review of patient data?

The provided information does not explicitly detail specific audit-trail features for Eko Analysis Software. For KardiaPro, the platform allows for the management and review of patient ECG, blood pressure, and weight data, with automated summary reports and trend visualization to support longitudinal reviews. This suggests a system for tracking and reviewing patient data over time, which can contribute to an audit trail.

What are the considerations for rolling out these tools across multiple clinical sites or a larger health system?

Eko Analysis Software is designed to scale detection capabilities across an entire team or health system for earlier disease detection in any virtual or physical setting. Eko's EHR integration also supports simplified processes for incorporating health information into patient charts across an institution. KardiaPro is a web-based portal for remote monitoring, which inherently supports managing data from multiple patients across different locations. Its integration with EHRs and point-of-care solutions like KardiaStation suggests adaptability for multi-site deployments.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Eko Analysis Software or KardiaPro

Backers

Who funded each tool's parent company.

Eko Analysis Software

Dreamit Ventures